NPD_Face.png

Backed by Science

Blue light LED technology is backed by science and clinically proven to be one of the most effective treatments for acne. LUSTRE® ClearSkin devices have been the focus of rigorous clinical investigations, demonstrating their ability to safely and effectively reduce mild to moderate acne. Explore our studies to see the research, results, and real-world impact behind the technology.

Medical device cleared in the UK, EU, and USA
Drug-free, chemical-free treatment
Safe for daily use on sensitive skin
Easy to use at home
Helps prevent future breakouts

LUSTRE vs Competitors

See why LUSTRE stands out from the competition

Features LUSTRE® Competitors
Clinical Studies
Backed by published clinical research, not just claims
User Studies
Proven results in real-world users
Medical-Grade Technology
Same standards trusted by professionals
Scientifically Optimised Wavelengths
Targets acne at its source
Comfort-Fit Design
Easy, secure, and wearable during daily life
UK Brand
Designed and supported in the UK
Responsive Customer Support
Real people, here when you need us
Multiple Awards
Recognised by trusted industry experts
Doctor & Dermatologist Endorsed
Recommended by medical professionals
Used in Clinics & Spas
The same tech trusted in professional treatments
Lightweight & Travel-Friendly
Results that fit your lifestyle
Picture_2.png
Picture_1.png

Clinical Study 1

The clinical effectiveness of LUSTRE® SOLO for mild to moderate acne vulgaris, following standard instructions for use, was evaluated by three independent dermatologists from the European LED Academy.
Assessments were conducted using a standardised protocol and acne scoring system. All participants underwent a 4-week washout of other treatments prior to the study and used only the LUSTRE® SOLO device during the study period.

*Images from a 12-week clinical study by the European LED Academy.

Untitled_design_1_c4716bf0-5bf6-4bd8-979d-8a4fd7a0112e.jpg
Untitled_design_3f4491a3-a43a-45dd-9cf9-763f7397b608.jpg

Clinical Study 2

The clinical effectiveness of LUSTRE® SOLO for treating acne vulgaris was evaluated in a two-centre study conducted from April 2012 to May 2013.

Two independent physicians assessed 23 participants (21 female, 2 male) aged 15–37 years (mean age 25), who were randomly recruited from attendees at two aesthetic dermatology clinics. All participants had acne vulgaris graded 2–4 using the Investigator Global Assessment (IGA) system and underwent a 4-week washout period before treatment began.

Thousands_of_users.jpg

Trusted by Dermatologists, Loved by Users Worldwide

Clinical Trials

80% REDUCTION IN SKIN SEBUM
80% REDUCTION IN PORE SIZE
75% REDUCTION IN INFLAMMATORY ACNE

*12-week clinical study by European LED academy

£63.00

Acne gone within weeks. LUSTRE® SOLO is a clinically proven pure blue light device to eliminate mild to moderate acne - safely, gently and with no side effects.  Designed wi...